Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
Samantha B. Kemp, Noah Cheng, Nune Markosyan, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 298-311
Open Access | Times Cited: 220

Showing 51-75 of 220 citing articles:

The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?
Yuko Oya, Kazuyoshi Imaizumi, Tetsuya Mitsudomi
Lung Cancer (2024) Vol. 194, pp. 107886-107886
Open Access | Times Cited: 7
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Chiara Musiu, Francesca Lupo, Antonio De Agostini, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
Yuqing Lu, Yuewen Yang, Guanghao Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3360-3382
Open Access | Times Cited: 14
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 14
Advancements in Preclinical Models of Pancreatic Cancer
P Salu, Katie M. Reindl
Pancreas (2024) Vol. 53, Iss. 2, pp. e205-e220
Closed Access | Times Cited: 5
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
Daniel J. Zabransky, Yash Chhabra, Mitchell E. Fane, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1221-1236
Closed Access | Times Cited: 5
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer
Mi Rim Lee, Sang Myung Woo, Min Kyeong Kim, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1283-1295
Open Access | Times Cited: 5
Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
Szu-Aun Long, Amber M. Amparo, Grace Goodhart, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Pathways and mechanism of MRTX1133 binding to KRAS G12D elucidated by molecular dynamics simulations and Markov state models
Gao Tu, Yaguo Gong, Xiaojun Yao, et al.
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133374-133374
Closed Access | Times Cited: 5
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei
Jordi Martínez‐Quintanilla, Débora Cabot, Doménico Sabia, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 18, pp. 4082-4099
Open Access | Times Cited: 5
Macroautophagy/autophagy promotes resistance to KRASG12D-targeted therapy through glutathione synthesis
Leng Han, Lingjun Meng, Jiao Liu, et al.
Cancer Letters (2024) Vol. 604, pp. 217258-217258
Open Access | Times Cited: 5
Multi-dimensional analyses identify genes of high priority for pancreatic cancer research
Zeribe C. Nwosu, Heather Giza, Maya Nassif, et al.
JCI Insight (2025)
Open Access
Discovery of a tribenzophenazine analog for binding to the KRAS mRNA G-quadruplex structures in the cisplatin-resistant non-small cell lung cancer
Xiaodong Wang, Jia-Hong Lin, Ming-Hao Hu
Journal of Biological Chemistry (2025), pp. 108164-108164
Open Access
KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling
Emily L Lasse-Opsahl, Ivana Barravecchia, Elyse McLintock, et al.
JCI Insight (2025) Vol. 10, Iss. 1
Open Access
The Landmark Series: The Future of Pancreatic Cancer Clinical Trials
Yongwoo David Seo, Matthew H. G. Katz, Rebecca A. Snyder
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2777-2785
Closed Access
Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research (2025)
Open Access
Advancements in gene therapies targeting mutant KRAS in cancers
Yuhang Wang, Thuỳ Anh Bùi, Xinpu Yang, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access
Immune regulatory genes impact the hot/cold tumor microenvironment, affecting cancer treatment and patient outcomes
Mengmeng Sang, Jia Ge, Juan Ge, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Alternative driver pathways in peripheral nerve sheath tumors – including DICER1 and/or KRAS alterations
Hsin‐Yi Chang, Carla Saoud, Dianne Torrence, et al.
The Journal of Pathology (2025)
Closed Access
Proteogenomic analysis reveals Arp 2/3 complex as a common molecular mechanism in high risk pancreatic cysts and pancreatic cancer
A. K. M. Firoj Mahmud, Dina Gamaleldin Mansour Aly, Yelin Zhao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
STAT3 Inhibition Prevents Adaptive Resistance and Augments NK Cell Cytotoxicity to KRASG12C Inhibitors in Nonsmall Cell Lung Cancer
Zehao Pan, Yuxian Qian, Yajing Wang, et al.
Cancer Science (2025)
Open Access
KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC
Xiangyan Jiang, Tao Wang, Bin Zhao, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101966-101966
Open Access
Pan-cancer analysis to character the clinicopathological and genomic features of KRAS-mutated patients in China
Liyuan Wu, Wei Rao, Lei Guo, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access

Scroll to top